Reliq Sale Purchase Of Stock from 2010 to 2024
| RHT Stock | CAD 0.22 0.00 0.00% |
Sale Purchase Of Stock | First Reported 2010-12-31 | Previous Quarter 1.9 M | Current Value 1.9 M | Quarterly Volatility 842.1 K |
Check Reliq Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reliq Health's main balance sheet or income statement drivers, such as Total Revenue of 10.3 M, Gross Profit of 6.4 M or Other Operating Expenses of 20.3 M, as well as many indicators such as Price To Sales Ratio of 279, Ptb Ratio of 27.06 or Days Sales Outstanding of 2.5 K. Reliq financial statements analysis is a perfect complement when working with Reliq Health Valuation or Volatility modules.
Reliq | Sale Purchase Of Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Reliq Stock Analysis
When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.